NCT00548964View on ClinicalTrials.gov

Continuation Ketamine in Major Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Lithium

600-900mg of Li carbonate

DRUG

Ketamine

0.5mg/kg of ketamine

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

James Murrough

OTHER

NCT00548964 - Continuation Ketamine in Major Depression | Biotech Hunter | Biotech Hunter